2nd Quarter - Amendment

HANCE SCARBOROUGH for ALLIANCE FOR PHARMACY COMPOUNDING

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 18, 2024 $50,000 Replaced
2nd Quarter - Amendment (this page) Jul 18, 2024 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act

LobbyistCovered position, as disclosed
ROBERT DAVID PORE Legislative Director, Cong. Jim Turner
THERESA REED —
MICHAEL TOMBERLIN Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 167 (118th)

Pharmacy PHA

Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act

LobbyistCovered position, as disclosed
ROBERT DAVID PORE Legislative Director, Cong. Jim Turner
THERESA REED —
MICHAEL TOMBERLIN Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 167 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.